Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
33.5 DKK | -0.15% | -0.74% | +22.04% |
Mar. 13 | Össur hf. Appoints Caroline Vagner Rosenstand to the Audit Committee | CI |
Feb. 21 | Össur hf Establishes New Parent Organization to Be Named Embla Medical | CI |
Business Summary
Number of employees: 3,999
Sales per Business
DKK in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Prosthetics
50.7
%
| 3,226 | 63.4 % | 2,743 | 50.7 % | -14.96% |
Patient Care
35.7
%
| - | - | 1,930 | 35.7 % | - |
Bracing and Supports
18.6
%
| 1,861 | 36.6 % | 1,010 | 18.6 % | -45.75% |
Internal Product
-5.0
%
| - | - | -268 | -5.0 % | - |
Sales per region
DKK in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Americas
48.9
%
| 2,483 | 48.8 % | 2,647 | 48.9 % | +6.61% |
EMEA
42.8
%
| 2,166 | 42.6 % | 2,318 | 42.8 % | +6.99% |
APAC
8.3
%
| 438 | 8.6 % | 450 | 8.3 % | +2.81% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Sveinn Sölvason
CEO | Chief Executive Officer | 46 | 08-12-31 |
Director of Finance/CFO | 58 | 22-08-31 | |
Lukas Märklin
COO | Chief Operating Officer | - | 23-06-14 |
Chief Tech/Sci/R&D Officer | 42 | 08-12-31 | |
Investor Relations Contact | - | 17-02-28 | |
Jos Van Poorten
PRN | Corporate Officer/Principal | - | - |
Gudjon Karason
PRN | Corporate Officer/Principal | 55 | 97-12-31 |
Human Resources Officer | 46 | 99-12-31 | |
Ólafur Gylfason
PRN | Corporate Officer/Principal | 55 | 96-12-31 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 73 | 13-02-28 | |
Niels Jacobsen
CHM | Chairman | 66 | 04-12-31 |
Svafa Grönfeldt
BRD | Director/Board Member | 59 | 08-01-31 |
Director/Board Member | 55 | 08-12-31 | |
Director/Board Member | 67 | 21-03-07 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 427,636,122 | 207,135,435 ( 48.44 %) | 701,647 ( 0.1641 %) | 48.44 % |
Holdings
Name | Equities | % | Valuation |
---|---|---|---|
ÖSSUR HF. 0.16% | 701,647 | 0.16% | 3,279,912 $ |
Company contact information
Group companies
Name | Category and Sector |
---|---|
Össur Iceland ehf
Össur Iceland ehf Medical SpecialtiesHealth Technology Part of William Demant Fonden, Össur Iceland ehf provides non-invasive orthopedic products and support services. The private company is based in ReykjavÃk, Iceland. |
Medical Specialties
|
Össur Finance AG
|
Sector
Sales per Business
Sales per region
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+22.04% | 2.07B | |
-4.85% | 17.29B | |
+13.01% | 14.42B | |
+15.88% | 10.96B | |
-25.60% | 1.86B | |
+32.98% | 1.62B | |
0.00% | 638M | |
-4.65% | 496M | |
+14.66% | 117M | |
+9.97% | 86.62M |
- Stock
- Equities
- Stock Össur hf. - Nasdaq Copenhagen
- Company Össur hf.